REYON Pharmaceutical Co., Ltd. (102460.KS) KSC

Currency In KRW

AD

Valuation

Market Cap200.37B
Enterprise Value409.82B
P/E Ratio-5.15
PEG Ratio0.05
Price/Sales Ratio1.23
Price/Book Ratio0.91
Enterprise/Revenue2.69
Enterprise/EBITDA-25.05

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.24
Operating Margin-0.21
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.16

Income Statement

Revenue145.93B
Revenue/Share7,817.18
Gross Profit33.76B
EBITDA228.1M
Net Income-29.83B
Diluted EPS-1,604.66

Balance Sheet

Total Cash7.04B
Total Cash/Share383.65
Total Debt216.85B
Total Debt/Equity1.11
Current Ratio0.5
Book Value Per Share10,624.82

Price History

52-Week Change-10.09
52-Week High13,200
52-Week Low8,650
Moving Average 50 Days9,878.6
Moving Average 200 Days10,364.65

Statistics

Average Volume31,158
Shares Outstanding18.34M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor51:50
Last Split DateDecember 29, 2020
AD